Aquilion ONE / PRISM Edition Now Offers Precise IQ Engine (PIQE) DLR* and SilverBeam Filter* OTAWARA, Japan–(BUSINESS WIRE)–Canon Medical is breaking ground once again with the introduction of Precise IQ Engine (PIQE) DLR and SilverBeam filter in the latest version of the Aquilion ONE / PRISM edition. PIQE, super-resolution deep-learning […]
Coronary/Structural Heart
Milestone: MemorialCare Orange Coast Medical Center Performs 100th TAVR Procedure
FOUNTAIN VALLEY, CA – MemorialCare Orange Coast Medical Center (OCMC) has announced that its Transcatheter Aortic Valve Replacement (TAVR) Program’s cardiac team recently performed their 100th TAVR procedure. Transcatheter aortic valve replacement (TAVR) is a minimally-invasive procedure that allows the aortic valve in your heart to be replaced with a […]
The National Institute for Health and Care Excellence of The United Kingdom Provides Positive Guidance for Neovasc Reducer System
VANCOUVER and MINNEAPOLIS, Nov. 24, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) today announced that the United Kingdom’s Interventional Procedures Programme at the National Institute for Health and Care Excellence (“NICE”) has issued guidance supporting the implantation of the Neovasc Reducer™ (“Reducer”) in appropriate patients suffering from refractory […]
Ionis announces that Pfizer reports topline results from Phase 2b clinical study of vupanorsen
– Study met its primary endpoint, achieving statistically significant reduction in non-high density lipoprotein cholesterol (non-HDL-C) compared to placebo at all doses tested – Key secondary endpoints were met including statistically significant reductions in triglycerides and angiopoietin-like-3 (ANGPTL3) at all doses tested – Pfizer is continuing to review the findings […]
OMRON Healthcare Issues National Health Alert: Adults with High Blood Pressure Could Face Higher Heart Attack and Stroke Risk During Cold & Flu Season
New study shows hypertensive adults can face six times higher heart attack risk after a bout with the seasonal flu LAKE FOREST, Ill., Nov. 23, 2021 /PRNewswire/ — As cold and flu season intensifies across the U.S., global heart health leader OMRON Healthcare, Inc., is issuing a national health alert to the increased […]
Le Bonheur first in region to perform pulmonary valve replacement for tetralogy of Fallot via catheterization using newly FDA-approved Harmony valve
MEMPHIS, Tenn., Nov. 22, 2021 /PRNewswire/ — Tony and Karyn Tanner of Bossier City, La., knew that this day was coming sooner rather than later for their 17-year-old daughter Madi. Born with tetralogy of Fallot (TOF), a congenital heart defect that changes the flow of blood through the heart, she needed a pulmonary valve replacement, […]
NeoChord Announces Positive 30-day Results with Transcatheter NeXuS System for Mitral Chordal Repair Using Multiple Chords to a Single Anchor
ST. LOUIS PARK, Minn., Nov. 22, 2021 (GLOBE NEWSWIRE) — NeoChord, Inc., a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation, announced positive 30-day results following the first successful worldwide procedure using multiple chords to a single anchor. The […]
Intellia Therapeutics Announces Expansion of Ongoing Phase 1 Study of NTLA-2001 to Include Adults with Transthyretin Amyloidosis with Cardiomyopathy (ATTR-CM)
Approved protocol amendment enables enrollment of ATTR-CM patients in the ongoing first-in-human study of NTLA-2001, a systemically delivered CRISPR/Cas9-based therapy CAMBRIDGE, Mass., Nov. 22, 2021 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA) announced today that the United Kingdom Medicines and Healthcare products Regulatory Agency (MHRA) has approved a protocol amendment […]
Bristol Myers Squibb Announces New PDUFA Date for Mavacamten
PRINCETON, N.J.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has extended the review of the New Drug Application (NDA) for mavacamten for the treatment of patients with symptomatic obstructive hypertrophic cardiomyopathy (oHCM) to April 28, 2022. The FDA notified Bristol Myers Squibb on […]
Proximo Medical Named Commercialization Partner for Acarix
LONGMONT, Colo., Nov. 18, 2021 /PRNewswire/ — Proximo Medical, LLC, a business acceleration solution that addresses medical device commercialization challenges among startup and established medical device technologies looking to expand adoption in the U.S., today announced a partnership with Acarix, a Swedish medical device company that provides innovative solutions for rapid AI-based rule out of […]



